Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
2,121
Views
19
CrossRef citations to date
0
Altmetric
Brief Report

Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy

Cyrill A. Rentscha Department of Urology, University Hospital Basel, University of Basel, Basel, SwitzerlandView further author information
,
Piet Bossharda Department of Urology, University Hospital Basel, University of Basel, Basel, Switzerland;b Department of Urology, University Hospital Bern, University of Bern, Bern, SwitzerlandORCID Iconhttps://orcid.org/0000-0001-8203-4463View further author information
ORCID Icon,
Grégoire Mayorc Department of Urology, University Hospital Geneva, University of Geneva, Geneva, SwitzerlandView further author information
,
Malte Riekena Department of Urology, University Hospital Basel, University of Basel, Basel, SwitzerlandView further author information
,
Heike Püschela Department of Urology, University Hospital Basel, University of Basel, Basel, SwitzerlandView further author information
,
Grégory Wirthc Department of Urology, University Hospital Geneva, University of Geneva, Geneva, SwitzerlandView further author information
,
Richard Cathomasd Department of Oncology, Cantonal Hospital Chur, Chur, SwitzerlandView further author information
,
Gerald P. Parzmaire Vakzine Projekt Management GmbH, Hannover, GermanyView further author information
,
Leander Grodee Vakzine Projekt Management GmbH, Hannover, GermanyView further author information
,
Bernd Eiselee Vakzine Projekt Management GmbH, Hannover, GermanyView further author information
,
Hitt Sharmaf Serum Institute of India Pvt. Ltd., Pune, IndiaView further author information
,
Manish Guptaf Serum Institute of India Pvt. Ltd., Pune, IndiaView further author information
,
Sunil Gairolaf Serum Institute of India Pvt. Ltd., Pune, IndiaORCID Iconhttps://orcid.org/0000-0003-4093-9736View further author information
ORCID Icon,
Umesh Shaligramf Serum Institute of India Pvt. Ltd., Pune, IndiaView further author information
,
Daniel Goldenbergerg Department of Clinical Bacteriology & Mycology, University Hospital Basel, University of Basel, Basel, SwitzerlandView further author information
,
François Spertinih Division of Immunology and Allergy, Lausanne University Hospital, Lausanne, SwitzerlandView further author information
,
Régine Audranh Division of Immunology and Allergy, Lausanne University Hospital, Lausanne, SwitzerlandORCID Iconhttps://orcid.org/0000-0002-5071-8403View further author information
ORCID Icon,
Milica Enoiui SAKK Coordinating Center, Bern, SwitzerlandView further author information
,
Simona Berardii SAKK Coordinating Center, Bern, SwitzerlandView further author information
,
Stefanie Hayozi SAKK Coordinating Center, Bern, SwitzerlandORCID Iconhttps://orcid.org/0000-0002-2265-6559View further author information
ORCID Icon &
Andreas Wickij Department of Oncology, University Hospital Basel, University of Basel, SwitzerlandView further author information
 show all
Article: 1748981 | Received 09 Jul 2019, Accepted 18 Jan 2020, Published online: 21 Apr 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.